The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study

Papapoulos, S.; Lippuner, K.; Roux, C.; Lin, C.J.F.; Kendler, D.L.; Lewiecki, E.M.; ... ; Bone, H.G. (2015)

Article / Letter to editor

• Bone mineral density
• Clinical trial
• Denosumab
• Fracture
• Osteoporosis
• Safety

• All authors: Papapoulos, S.; Lippuner, K.; Roux, C.; Lin, C.J.F.; Kendler, D.L.; Lewiecki, E.M.; Brandi, M.L.; Czerwinski, E.; Franek, E.; Lakatos, P.; Mautalen, C.; Minisola, S.; Reginster, J.Y.; Jensen, S.; Daizadeh, N.S.; Wang, A.; Gavin, M.; Libanati, C.; Wagman, R.B.; Bone, H.G.
• Date: 2015-12-31
• Journal: Osteoporosis International
• Volume: 26
• Issue: 12
• Pages: 2773 - 2783
• DOI: doi:10.1007/s00198-015-3234-7